Prelude Capital Management’s Avidity Biosciences RNA Stock Holding History

Prelude Capital Management’s Portfolio RNA Stock Details RNA Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	$8.07M	Buy
2024 Q2	–	Sell
2024 Q1	$629K	Buy
2023 Q2	–	Sell
2023 Q1	$341K	Buy